Related Experiment Video
Updated: May 13, 2026

Dual Effects of Melanoma Cell-derived Factors on Bone Marrow Adipocytes Differentiation
Published on: August 23, 2018
Differential expression and tumor necrosis factor-mediated regulation of TNFRSF11b/osteoprotegerin production by
Janine L Oliver1, Matthew P Alexander, Allison G Norrod
1Department of Microbiology, Immunology, and Cancer Biology, University of Virginia School of Medicine, Charlottesville, VA, USA.
Abstract:
Tumors escape host immune responses, in part, through the release of immunomodulatory factors and decoy receptors into their microenvironment. Several cancers express surface-bound and soluble members of the tumor necrosis factor (TNF) receptor superfamily, including TNFRSF11b/osteoprotegerin (OPG). In its physiologic role, OPG regulates bone remodeling through competition for osteoclast-activating cytokines and protects newly forming bone from T cell-mediated apoptosis. In multiple tumor types, OPG production is associated with an aggressive phenotype and increased metastasis to bone, but no study has examined OPG production in human metastatic melanoma. We demonstrate that a significant proportion of human metastatic melanomas constitutively produces OPG through a mechanism governed by membrane-bound TNF-α signaling through TNF receptor 1 (TNFR1). These observations both define a specific mechanism that regulates melanoma production of OPG and establish a new molecular target for the therapeutic regulation of OPG.
Insights
Metastatic melanomas produce osteoprotegerin (OPG), a factor linked to aggressive cancer. This production is regulated by tumor necrosis factor-alpha (TNF-α) signaling via TNF receptor 1 (TNFR1), offering a new therapeutic target.
Area of Science:
- Oncology
- Immunology
- Molecular Biology
Background:
- Tumors evade immune responses via secreted factors and decoy receptors.
- Osteoprotegerin (OPG), a TNF receptor superfamily member, regulates bone remodeling and T cell apoptosis.
- OPG production in cancers correlates with aggressive phenotypes and bone metastasis.
Purpose of the Study:
- To investigate OPG production in human metastatic melanoma.
- To elucidate the regulatory mechanism of OPG production in melanoma.
- To identify potential therapeutic targets for regulating OPG in melanoma.
Main Methods:
- Analysis of OPG expression in human metastatic melanoma samples.
- Investigation of the role of tumor necrosis factor-alpha (TNF-α) and TNF receptor 1 (TNFR1) signaling.
- Assessment of OPG production mechanisms.
Main Results:
- A significant proportion of human metastatic melanomas constitutively produce OPG.
- Melanoma OPG production is regulated by membrane-bound TNF-α signaling through TNFR1.
- This pathway represents a novel mechanism controlling OPG in melanoma.
Conclusions:
- Human metastatic melanomas produce OPG via a TNF-α/TNFR1-dependent mechanism.
- This finding establishes a specific regulatory pathway for OPG in melanoma.
- The TNF-α/TNFR1 pathway is a potential therapeutic target for managing OPG in metastatic melanoma.
More Related Videos
Related Concept Videos
TGF - β Signaling Pathway
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Regulation of Angiogenesis and Blood Supply

